Exosens (LSE:0EXO) EBITDA Margin %: 32.74% (As of Dec. 2025) — 28% Above Median


LSE:0EXO Exosens SA LSE:0EXO
46 GF Score
Price €21.00
! 3 Warning Signs
View Full Analysis

What is Exosens EBITDA Margin %?

Exosens LSE:0EXO 46 EBITDA Margin % is 32.74% as of Dec. 2025, which is 28% above its 10-year median of 25.66. GuruFocus rates LSE:0EXO with a GF Score™ of 46/100. The stock has 3 warning signs investors should review. Among 3,039 Industrial Products companies, Exosens ranks better than 95.06% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Exosens's EBITDA for the six months ended in Dec. 2025 was €52.0 Mil. Exosens's Revenue for the six months ended in Dec. 2025 was €158.9 Mil. Therefore, Exosens's EBITDA margin for the quarter that ended in Dec. 2025 was 32.74%.


Exosens  (LSE:0EXO) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Exosens EBITDA Margin % Related Terms


Exosens EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Exosens's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Exosens EBITDA Margin % Chart

Exosens Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBITDA Margin %
Get a 7-Day Free Trial -60.89 25.53 25.79 30.35 31.32

Exosens Semi-Annual Data
Dec20 Dec21 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only 25.42 25.78 33.38 28.19 32.74

LSE:0EXO vs VRT, BE, NVT: EBITDA Margin % Comparison

For the Electrical Equipment & Parts subindustry, Exosens's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Exosens EBITDA Margin % vs Industrial Products Industry

For the Industrial Products industry and Industrials sector, Exosens's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Exosens's EBITDA Margin % falls into.


LSE:0EXO
46GF Score
Exosens SA LSE:0EXO
EBITDA Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Exosens EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Exosens's EBITDA Margin % for the fiscal year that ended in Dec. 2025 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=120.1/383.4
=31.32 %

Exosens's EBITDA Margin % for the quarter that ended in Dec. 2025 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=52.017/158.885
=32.74 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 32.74% mean?
Exosens (LSE:0EXO) has a EBITDA Margin % of 32.74% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Exosens and its competitors. This is 28% above median its historical median of 25.66. According to the industry distribution chart, Exosens ranks #150 out of 3039 companies in the Industrial Products industry, placing it in the top 4.9%.
Is Exosens' EBITDA Margin % too high?
Exosens' current EBITDA Margin % of 32.74% is 28% above median its 10-year median of 25.66. The Industrial Products industry median EBITDA Margin % is 9.45. Exosens' value of 32.74% is 246.5% above this industry median. Based on the distribution chart, Exosens ranks #150 out of 3039 companies in the Industrial Products industry, which is in the top quartile — a strong position relative to peers. Overall, Exosens has a GF Score™ of 46/100, reflecting its overall financial health beyond just this single metric.
How does Exosens' EBITDA Margin % compare to VRT and BE?
According to the Industrial Products industry distribution chart, Exosens ranks #150 out of 3039 companies for EBITDA Margin %. This places Exosens in the top 5% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 9.45. Exosens' value of 32.74% is 246.5% above this benchmark. While the company's 10-year median is 25.66 vs. the industry median of 9.45, Exosens has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for an Industrial Products company?
The median EBITDA Margin % among Industrial Products companies is 9.45, based on 3,039 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Exosens's current EBITDA Margin % of 32.74% is 246.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Exosens and its competitors. For the Industrial Products industry, the median EBITDA Margin % is 9.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Exosens's current EBITDA Margin % is 32.74%, which is 28% above median its own 10-year median of 25.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Exosens stock overvalued right now?
Exosens (LSE:0EXO) has a current EBITDA Margin % of 32.74%. The current EBITDA Margin % is 32.74%, which is 28% above median its 10-year median of 25.66 and 246.5% above the Industrial Products industry median of 9.45. Exosens' overall GF Score™ is 46/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Exosens (LSE:0EXO), the current EBITDA Margin % is 32.74% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Exosens Business Description

Address 18 Avenue de Pythagore, Domaine de Pelus, Axis Business Park Bat 5E, Merignac, FRA, 33700
Exosens SA is a high-tech company specializing in electro-optical technologies for amplification, detection, and imaging. It offers products such as night vision tubes, ultraviolet cameras, travelling wave tubes, and various detectors for defense, life sciences, nuclear, and industrial sectors. With multiple production sites in Europe and North America. The company's activities are organized into two main segments: Amplification, which focuses on electron or electromagnetic wave amplification systems mainly used in defense night vision equipment and generates the majority of its revenue, and Detection & Imaging, which provides high value-added components for commercial markets such as nuclear power, research, and industrial applications.
46GF Score

Get the complete analysis for LSE:0EXO

EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€21.00
Price